Clinical trial
A Single-Arm, Open-Label, Phase 1/2 Clinical Trial of ZVS203e in Subjects With Retinitis Pigmentosa Associated With RHO Mutation
NCT06952842 is registered in ClinicalTrials.gov with Chigenovo Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Arm, Open-Label, Phase 1/2 Clinical Trial of ZVS203e in Subjects With Retinitis Pigmentosa Associated With RHO Mutation
- Lead sponsor
- Chigenovo Co., Ltd
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- August 4, 2025
- Completion date
- June 18, 2045
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.